Duke researchers use gene therapy to direct stem cells into becoming new cartilage on a synthetic scaffold even after implantation into a living body
By combining a synthetic scaffolding material with gene delivery techniques, researchers at Duke University are getting closer to being able to generate replacement cartilage where it’s needed in the body.
Performing tissue repair with stem cells typically requires applying copious amounts of growth factor proteins—a task that is very expensive and becomes challenging once the developing material is implanted within a body. In a new study, however, Duke researchers found a way around this limitation by genetically altering the stem cells to make the necessary growth factors all on their own.
They incorporated viruses used to deliver gene therapy to the stem cells into a synthetic material that serves as a template for tissue growth. The resulting material is like a computer; the scaffold provides the hardware and the virus provides the software that programs the stem cells to produce the desired tissue.
The study appears online the week of Feb. 17 in the Proceedings of the National Academy of Sciences.
Farshid Guilak, director of orthopaedic research at Duke University Medical Center, has spent years developing biodegradable synthetic scaffolding that mimics the mechanical properties of cartilage. One challenge he and all biomedical researchers face is getting stem cells to form cartilage within and around the scaffolding, especially after it is implanted into a living being.
The traditional approach has been to introduce growth factor proteins, which signal the stem cells to differentiate into cartilage. Once the process is under way, the growing cartilage can be implanted where needed.
“But a major limitation in engineering tissue replacements has been the difficulty in delivering growth factors to the stem cells once they are implanted in the body,” said Guilak, who is also a professor in Duke’s Department of Biomedical Engineering. “There’s a limited amount of growth factor that you can put into the scaffolding, and once it’s released, it’s all gone. We need a method for long-term delivery of growth factors, and that’s where the gene therapy comes in.”
The Latest on: Replacement Tissue
via Google News
The Latest on: Replacement Tissue
- Scientists create synthetic mouse embryos, a potential key to healing humanson August 1, 2022 at 2:10 pm
Stem cell researchers in Israel have created synthetic mouse embryos without using a sperm or egg, then grown them in an artificial womb for eight days, a development that opens a window into a ...
- RTT Medical joins RegenMed Hub Innovation Acceleratoron July 31, 2022 at 5:00 pm
RTT Medical is the newest tenant of the Innovation Accelerator, a support ecosystem created by the RegenMed Development Organization (ReMDO) to help companies with new or emerging regenerative ...
- Dr Kaushik Patel introduces revolutionary ABC Robo Technique - A revolutionary robotic knee replacement surgery techniqueon July 28, 2022 at 4:27 pm
In the realm of robotic joint replacement, ABC Robo Technique will be a ground-breaking innovation. This procedure will help maximise result accuracy with fewer chances of mistakes. The NAVIO Surgical ...
- Soft Tissue Anchors Market Surpass $912.27 million Globally, by 2028 at 5.1% CAGR - Exclusive Study by The Insight Partnerson July 25, 2022 at 4:05 am
Soft Tissue Anchors Market is expected to grow from US$ 677.68 million in 2022 to US$ 912.27 million by 2028; it is estimated to grow at a CAGR of 5.1% from 2022 to 2028. New York, July 25, 2022 ...
- Doctors in Chennai hospital choose surgical valve replacement for man with deformities, single kidneyon July 21, 2022 at 6:29 am
A team of Madras Medical Mission in Chennai decided against Transcatheter Aortic Valve Implantation (TAVI) for a 51-year-old man, who was born with one kidney, considering his multiple co-morbidities ...
- Soft Tissue Anchors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Tying Type, Material, and End Useron July 20, 2022 at 3:58 am
The soft tissue anchors market is expected to grow from US$ 677. 68 million in 2022 to US$ 912. 27 million by 2028; it is expected to grow with a CAGR of 5. 1% from 2022 to 2028. The increase in ...
- Soft Tissue Repair Market worth USD 21.4 billion by 2030, says Global Market Insights Inc.on July 20, 2022 at 3:40 am
These soft tissue repair products can be used in several practices comprising hernia repair, skin repair, and orthopedic among others for repair and replacement of damaged tissue. Tissue matrix is ...
- Soft Tissue Repair Market worth USD 21.4 billion by 2030, says Global Market Insights Inc.on July 20, 2022 at 3:35 am
Some of the major market players operating in the soft tissue repair industry include Smith & Nephew Plc., Medtronic Plc., Arthrex, Inc, Medprin Biotech, Zimmer Biomet, Stryker Corporation, and Baxter ...
- New robot revolutionizes knee replacement surgery recovery timeon July 19, 2022 at 2:32 pm
Surgeons perform more than a million knee replacements a year in the U.S. Many patients put it off and live with pain for years because the recovery from replacement surgery is so daunting.
- Renowned Hip and Knee Replacement Surgeonon July 18, 2022 at 8:04 am
Dr. Richard Berger is a renowned hip and knee replacement surgeon at Midwest Orthapaedics at Rush and assistant professor at Rush University Medical Center, known for pioneering a minimally invasive ...
via Bing News